These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Genes, proteases, cortical spreading depression and migraine: impact on pathophysiology and treatment. Moskowitz MA Funct Neurol; 2007; 22(3):133-6. PubMed ID: 17925161 [TBL] [Abstract][Full Text] [Related]
23. Functional characterization of acid-sensing ion channels in cultured neurons of rat inferior colliculus. Zhang M; Gong N; Lu YG; Jia NL; Xu TL; Chen L Neuroscience; 2008 Jun; 154(2):461-72. PubMed ID: 18456416 [TBL] [Abstract][Full Text] [Related]
24. Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials. Olesen J Eur Neurol; 1990; 30 Suppl 2():31-4; discussion 39-41. PubMed ID: 2180716 [TBL] [Abstract][Full Text] [Related]
25. Neurophysiology and neuromodulators. Aguggia M; D'Andrea G; Bussone G Neurol Sci; 2007 May; 28 Suppl 2():S97-S100. PubMed ID: 17508189 [TBL] [Abstract][Full Text] [Related]
27. Ion channel modulators: new targets and new indications for old targets. Priest B; Kaczorowski GJ; Garcia ML Curr Opin Drug Discov Devel; 2006 Sep; 9(5):587-94. PubMed ID: 17002219 [TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology of migraine: models to explain the generation of migraine headache]. Ebersberger A Anaesthesist; 2002 Aug; 51(8):661-7. PubMed ID: 12391526 [TBL] [Abstract][Full Text] [Related]
30. The impact of pharmacogenetics for migraine. Ophoff RA; van den Maagdenberg AM; Roon KI; Ferrari MD; Frants RR Eur J Pharmacol; 2001 Feb; 413(1):1-10. PubMed ID: 11173058 [TBL] [Abstract][Full Text] [Related]
31. The future of acute care and prevention in headache. Krymchantowski AV; Rapoport AM; Jevoux CC Neurol Sci; 2007 May; 28 Suppl 2():S166-78. PubMed ID: 17508166 [TBL] [Abstract][Full Text] [Related]
32. [Migraine in childhood and adolescence: a retrospective review of hospital cases]. Castro-Gago M; Couceiro JA; Novo-Rodríguez I; Méndez MJ; Fernández Seara MJ; Eirís J Rev Neurol; 1995; 23(122):769-72. PubMed ID: 7497237 [TBL] [Abstract][Full Text] [Related]
33. Guidelines on migraine: part 5. Recommendations for specific prophylactic drugs. Morey SS Am Fam Physician; 2000 Dec; 62(11):2535-9. PubMed ID: 11130237 [No Abstract] [Full Text] [Related]
34. Which therapy for which patient? Pierangeli G; Cevoli S; Sancisi E; Grimaldi D; Zanigni S; Montagna P; Cortelli P Neurol Sci; 2006 May; 27 Suppl 2():S153-8. PubMed ID: 16688621 [TBL] [Abstract][Full Text] [Related]
35. Localization of amiloride-sensitive sodium current and voltage-gated calcium currents in rat fungiform taste cells. Bigiani A; Cuoghi V J Neurophysiol; 2007 Oct; 98(4):2483-7. PubMed ID: 17686911 [TBL] [Abstract][Full Text] [Related]
36. Sodium channel antagonists for the treatment of migraine. Chiossi L; Negro A; Capi M; Lionetto L; Martelletti P Expert Opin Pharmacother; 2014 Aug; 15(12):1697-706. PubMed ID: 24941134 [TBL] [Abstract][Full Text] [Related]
37. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings. Sitges M; Chiu LM; Nekrassov V Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162 [TBL] [Abstract][Full Text] [Related]